Coherus BioSciences Inc
NASDAQ:CHRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Coherus BioSciences Inc
NASDAQ:CHRS
|
US |
|
X
|
X Fab Silicon Foundries EV
OTC:XFABF
|
BE |
|
D
|
Delta Israel Brands Ltd
TASE:DLTI
|
IL |
|
ALK-Abello A/S
OTC:AKBLF
|
DK |
|
Blue Hat Interactive Entertainment Technology
F:4Y80
|
CN |
|
Advantage Energy Ltd
TSX:AAV
|
CA |
|
Bimobject AB
F:BOJB
|
SE |
|
Vicat SA
PAR:VCT
|
FR |
|
Treasury Wine Estates Ltd
ASX:TWE
|
AU |
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
US |
|
Allsec Technologies Ltd
NSE:ALLSEC
|
IN |
|
C
|
Costco Wholesale Corp
DUS:CTO
|
US |
|
B
|
Beiersdorf AG
XHAM:BEI
|
DE |
|
B
|
Beiersdorf AG
DUS:BEI
|
DE |
Shareholder Yield
Current shareholder yield for CHRS is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CHRS Price
Coherus BioSciences Inc
| Average Annual Return | -35.91% |
| Standard Deviation of Annual Returns | 40.18% |
| Max Drawdown | -96% |
| Market Capitalization | 226.7m USD |
| Shares Outstanding | 154 250 000 |
| Percentage of Shares Shorted | 18.78% |
